Insider Trading Alert - ALGN, PCTY And ATRC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 18, 2015, 93 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $500.00 to $575,784,180.28.

Highlighted Stocks Traded by Insiders:

Align Technology (ALGN) - FREE Research Report

Erfurth Jennifer, who is VP, Global Human Resources at Align Technology, sold 2,400 shares at $59.27 on May 18, 2015. Following this transaction, the VP, Global Human Resources owned 309 shares meaning that the stake was reduced by 88.59% with the 2,400-share transaction.

The shares most recently traded at $59.33, up $0.06, or 0.1% since the insider transaction. Historical insider transactions for Align Technology go as follows:

  • 4-Week # shares sold: 41,892
  • 12-Week # shares sold: 60,374
  • 24-Week # shares sold: 60,374

The average volume for Align Technology has been 874,300 shares per day over the past 30 days. Align Technology has a market cap of $4.8 billion and is part of the health care sector and health services industry. Shares are up 7.06% year-to-date as of the close of trading on Monday.

Align Technology, Inc. The company has a P/E ratio of 32.6. Currently, there are 8 analysts who rate Align Technology a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ALGN - FREE

TheStreet Quant Ratings rates Align Technology as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, expanding profit margins and growth in earnings per share. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Align Technology Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Paylocity (PCTY) - FREE Research Report

Beauchamp Steven R, who is President and CEO at Paylocity, sold 40,000 shares at $33.25 on May 18, 2015. Following this transaction, the President and CEO owned 2.7 million shares meaning that the stake was reduced by 1.44% with the 40,000-share transaction.

The shares most recently traded at $33.55, up $0.30, or 0.91% since the insider transaction. Historical insider transactions for Paylocity go as follows:

  • 4-Week # shares sold: 35,000
  • 12-Week # shares sold: 73,000
  • 24-Week # shares sold: 2.5 million

The average volume for Paylocity has been 201,800 shares per day over the past 30 days. Paylocity has a market cap of $1.7 billion and is part of the technology sector and computer software & services industry. Shares are up 28.95% year-to-date as of the close of trading on Monday.

Paylocity Holding Corporation provides cloud-based payroll and human capital management (HCM) software solutions for medium-sized organizations in the United States. Currently, there are 4 analysts who rate Paylocity a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on PCTY - FREE

TheStreet Quant Ratings rates Paylocity as a sell. The area that we feel has been the company's primary weakness has been its feeble growth in its earnings per share. Get the full Paylocity Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AtriCure (ATRC) - FREE Research Report

Krell Elizabeth D, who is Director at AtriCure, sold 10,000 shares at $21.77 on May 18, 2015. Following this transaction, the Director owned 7,162 shares meaning that the stake was reduced by 58.27% with the 10,000-share transaction.

The shares most recently traded at $22.09, up $0.32, or 1.45% since the insider transaction. Historical insider transactions for AtriCure go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 32,544
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 32,544
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 32,544

The average volume for AtriCure has been 182,400 shares per day over the past 30 days. AtriCure has a market cap of $608.8 million and is part of the health care sector and health services industry. Shares are up 9.72% year-to-date as of the close of trading on Monday.

AtriCure, Inc., a medical device company, provides atrial fibrillation solutions worldwide. Currently, there are 7 analysts who rate AtriCure a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ATRC - FREE

TheStreet Quant Ratings rates AtriCure as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the growth in the company's earnings per share has not been good. Get the full AtriCure Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Stocks Trade Lower as Rates Continue Rising; Boeing Holds Gains

Stocks Trade Lower as Rates Continue Rising; Boeing Holds Gains

4 Stocks Making Important Moves Wednesday

4 Stocks Making Important Moves Wednesday

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday